Skip to main navigation Skip to search Skip to main content

Hepatitis B immunization in low birthweight infants: Do they need an additional dose?

  • N. K. Arora
  • , S. Ganguly
  • , S. N. Agadi
  • , M. Irshad
  • , R. Kohli
  • , M. Deo
  • , V. K. Paul
  • , A. K. Deorari
  • , H. Chellani
  • , M. S. Prasad
  • , D. Sharma

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: To determine the influence of gestation and weight on the development of protective anti-HB levels and geometric mean titres after three doses of HBV vaccine and to ascertain the need for a fourth dose in low birthweight infants. Methods: Hepatitis B vaccine (Enivac HB®, Panacea Biotec Ltd., India) was given to 82 preterm (PT) and 60 term intrauterine growth-retarded (T-IUGR) infants at birth and at 6, 10 and 14 wk of life. Results: Protective anti-HB levels (> 10 mIU/ml) were reached in 86.6% (71/82) of PT infants and 96.7% (58/60) of T-IUGR infants after three doses of HBV vaccine (p = 0.044). The odds of having a protective response after the third dose of HBV vaccine was 1.25 (95% CI 1.02-1.53) with every one-week increase in gestation (p = 0.032). Birthweight was not associated with the development of a protective immune response. After the third dose, only 66.7% (8/12) of the PT infants whose mothers had anti-HB antibodies, developed protective anti-HB levels compared with 90% (63/70) of those with no maternal antibodies (p = 0.028). In PT infants after the fourth dose, there was a significant increase in the proportion of infants with protective antibody levels (8.6%, 95% CI 0.6-16.6%) among those with no maternal antibodies and 12.2% overall (95% CI 6.0-21.3) (p = 0.031 to 0.002) over that reached with the third dose. Administration of the fourth dose to T-IUGR infants did not confer such a benefit. Conclusion: In HBV-endemic areas, PT infants, irrespective of their birthweights, may benefit from an additional dose of hepatitis B vaccine in a schedule starting at birth. This approach will prevent vertical transmission and bring their immune response up to par with term infants. Term intrauterine growth-retarded infants should be vaccinated as per the schedule recommended for normal term infants. However, studies in other settings with different vaccine formulations and a longer follow-up period will be required before this strategy can be practised more widely.

Original languageEnglish (US)
Pages (from-to)995-1001
Number of pages7
JournalActa Paediatrica, International Journal of Paediatrics
Volume91
Issue number9
DOIs
StatePublished - 2002
Externally publishedYes

Keywords

  • Hepatitis B immunization
  • Intrauterine growth retardation
  • Low birthweight
  • Preterm infants
  • Term intrauterine growth retarded infants

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Hepatitis B immunization in low birthweight infants: Do they need an additional dose?'. Together they form a unique fingerprint.

Cite this